BibTex RIS Kaynak Göster

Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem

Yıl 2013, , 167 - 170, 01.10.2013
https://doi.org/10.5222/j.child.2013.167

Öz

Herediter anjiyoödem HA ; yineleyen anjiyoödem atakları ile seyreden C1 inhibitör eksikliğine veya fonksiyon bozuk- luğuna bağlı gelişen otozomal dominant kalıtılan bir has- talıktır. Her iki cinste de eşit oranda görülen hastalığın prevalansının 50.000 ila 100.000 doğumda bir olduğu tah- min edilmektedir. Anjiyoödem en sık ekstremiteler, orofa- rinkste ve visseral organlarda görülür. Hastalığın 3 tipi tanımlanmıştır. En sık görülen Tip 1 HA’dir; hastaların %80-85’ini kapsar ve C1 inhibitör düzeyi düşük ve fonksi- yonu bozuktur. HA Tip 2’de ise C1 inhibitör düzeyi normal veya artmış iken, fonksiyonu bozuktur. Son yıllarda, özellik- le gebelerde ve östrojen tedavisi almakta olan kadınlarda Tip 3 HA tanımlanmıştır. Burada yineleyen anjiyoödem ve karın ağrısı ile gelen ve HA Tip 2 tanısı konulan 6 yaşında bir erkek çocuğu sunulmuştur. HA tanısından şüphelenildi- ğinde, C1INH düzeyi normal bulunduğunda C1INH fonksi- yonunun da ölçülmesi önemlidir

Kaynakça

  • 1. Agostoni A, Cicardi M. Hereditary and acquired C-1 inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992;71(4):206-15. http://dx.doi.org/10.1097/00005792-199207000-00003
  • 2. Bork K, Gül D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007;120:987-92. http://dx.doi.org/10.1016/j.amjmed.2007.08.021
  • 3. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 2006;26:709-24. http://dx.doi.org/10.1016/j.iac.2006.09.003
  • 4. Osler W. Hereditary angio-neurotic oedema. Am J Med Sci 1888;95:362-7. http://dx.doi.org/10.1097/00000441-188804000-00004
  • 5. Frank MM. Hereditary angioedema: a half century of progress. J Allergy Clin Immunol 2004;114:626-8. http://dx.doi.org/10.1016/j.jaci.2004.06.035
  • 6. Fabiani JE, Paulin P, Simkin G, Leoni J, Palombarani S, Squiquera L. Hereditary angioedema: therapeutic effect of danazol on C4 and C1 esterase inhibitors. Ann Allergy 1990; 64:388-2.
  • 7. Witschi A, Krahenbühl L, Frei E, Saltzman J, Spath PJ, Müller UR. Colorectal intussusception: An unusual gastrointestinal complication of hereditary angioedema. Int Arch Allergy Immunol 1996;111:96-8. http://dx.doi.org/10.1159/000237352
  • 8. Zuraw BL. Hereditary angioedema. N Engl J Med 2008;359: 1027-36. http://dx.doi.org/10.1056/NEJMcp0803977
  • 9. Davis AE III. Hereditary angioedema: a current state-of-theart review, III: mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol 2008;100(suppl2):S7-12. http://dx.doi.org/10.1016/S1081-1206(10)60580-7
  • 10. Dewald G, Bork K. Missense mutations in the coagulation factor XII gene in hereditary angioedema with normal C1 inhibitor. Biochemical and Biophysical Research Communications 2006;343:1286-9. http://dx.doi.org/10.1016/j.bbrc.2006.03.092
  • 11. Davis AE 3rd: The pathogenesis of hereditary angioedema. Transfus Apher Sci 2003;29:195-203. http://dx.doi.org/10.1016/j.transci.2003.08.012
  • 12. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Exp Immunol 2005;139:379-94.
  • 13. Winnewisser J, Rossi M, Späth P, et al. Type I hereditary angio-oedema: variability of clinical presentation and course within two large kindreds. J Intern Med 1997;241:39-46. http://dx.doi.org/10.1046/j.1365-2796.1997.76893000.x
  • 14. Bowen T, Cicardi M, Bork K, et al. Hereditary angioedema: a current state-of-the art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the diagnosis, therapy, and management of Hereditary angioedema. Ann Allergy Asthma Immunol 2008;100(Suppl 2):S30-40. http://dx.doi.org/10.1016/S1081-1206(10)60584-4
  • 15. Zuraw BL. Hereditary angioedema: a current state-of-the art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? Ann Allergy Asthma Immunol 2008;100(Suppl 2):S13-8. http://dx.doi.org/10.1016/S1081-1206(10)60581-9
  • 16. Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006;119:267-74. http://dx.doi.org/10.1016/j.amjmed.2005.09.064
  • 17. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 2006;26:653-68. http://dx.doi.org/10.1016/j.iac.2006.09.005
  • 18. Cugno M, Zanichelli A, Foieni F, et al. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009;15:69-78. http://dx.doi.org/10.1016/j.molmed.2008.12.001
  • 19. Quastel M, Harrison R, Cicardi M, et al. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 1983;71:1041-6. http://dx.doi.org/10.1172/JCI110831
  • 20. www.aid.org.tr- Herediter anjiyoödem çalışma grubu

Hereditary Angioedema: A Rare Cause of Recurrent Angioedema

Yıl 2013, , 167 - 170, 01.10.2013
https://doi.org/10.5222/j.child.2013.167

Öz

Hereditary angioedema HA is a rare, autosomal-dominant genetic disorder presenting with recurrent attacks of angi- oedema which develop secondary deficiency of CI inhibi- tors or related dysfunction. Men and women are equally affected. The prevalence of HA is predicted to be 1 per 50,000 to 150,000 in the general population. The most commonly involved organs include the extremites, face, neck, upper respiratory tract, genital region and the gast- rointestinal tract. There are 3 types of HAE. Type I HA is defined by low plasma levels of a normal C1-INH protein. Type II HA is characterized by the presence of normal or elevated levels of a dysfunctional C1-INH. Type III HA has been recently identified as an estrogen-dependent inherited form of angioedema occurring mainly in women. Herein, a 6-year-old boy who presented with recurrent episodes of angioedema and abdominal pain and diagnosed with type II HA is reported. It is important to highlight the measure- ment of C1INH function in patients with suspect but with normal C1INH levels

Kaynakça

  • 1. Agostoni A, Cicardi M. Hereditary and acquired C-1 inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992;71(4):206-15. http://dx.doi.org/10.1097/00005792-199207000-00003
  • 2. Bork K, Gül D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007;120:987-92. http://dx.doi.org/10.1016/j.amjmed.2007.08.021
  • 3. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 2006;26:709-24. http://dx.doi.org/10.1016/j.iac.2006.09.003
  • 4. Osler W. Hereditary angio-neurotic oedema. Am J Med Sci 1888;95:362-7. http://dx.doi.org/10.1097/00000441-188804000-00004
  • 5. Frank MM. Hereditary angioedema: a half century of progress. J Allergy Clin Immunol 2004;114:626-8. http://dx.doi.org/10.1016/j.jaci.2004.06.035
  • 6. Fabiani JE, Paulin P, Simkin G, Leoni J, Palombarani S, Squiquera L. Hereditary angioedema: therapeutic effect of danazol on C4 and C1 esterase inhibitors. Ann Allergy 1990; 64:388-2.
  • 7. Witschi A, Krahenbühl L, Frei E, Saltzman J, Spath PJ, Müller UR. Colorectal intussusception: An unusual gastrointestinal complication of hereditary angioedema. Int Arch Allergy Immunol 1996;111:96-8. http://dx.doi.org/10.1159/000237352
  • 8. Zuraw BL. Hereditary angioedema. N Engl J Med 2008;359: 1027-36. http://dx.doi.org/10.1056/NEJMcp0803977
  • 9. Davis AE III. Hereditary angioedema: a current state-of-theart review, III: mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol 2008;100(suppl2):S7-12. http://dx.doi.org/10.1016/S1081-1206(10)60580-7
  • 10. Dewald G, Bork K. Missense mutations in the coagulation factor XII gene in hereditary angioedema with normal C1 inhibitor. Biochemical and Biophysical Research Communications 2006;343:1286-9. http://dx.doi.org/10.1016/j.bbrc.2006.03.092
  • 11. Davis AE 3rd: The pathogenesis of hereditary angioedema. Transfus Apher Sci 2003;29:195-203. http://dx.doi.org/10.1016/j.transci.2003.08.012
  • 12. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C, et al. C1 inhibitor deficiency: consensus document. Exp Immunol 2005;139:379-94.
  • 13. Winnewisser J, Rossi M, Späth P, et al. Type I hereditary angio-oedema: variability of clinical presentation and course within two large kindreds. J Intern Med 1997;241:39-46. http://dx.doi.org/10.1046/j.1365-2796.1997.76893000.x
  • 14. Bowen T, Cicardi M, Bork K, et al. Hereditary angioedema: a current state-of-the art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the diagnosis, therapy, and management of Hereditary angioedema. Ann Allergy Asthma Immunol 2008;100(Suppl 2):S30-40. http://dx.doi.org/10.1016/S1081-1206(10)60584-4
  • 15. Zuraw BL. Hereditary angioedema: a current state-of-the art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? Ann Allergy Asthma Immunol 2008;100(Suppl 2):S13-8. http://dx.doi.org/10.1016/S1081-1206(10)60581-9
  • 16. Bork K, Meng G, Staubach P, et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006;119:267-74. http://dx.doi.org/10.1016/j.amjmed.2005.09.064
  • 17. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 2006;26:653-68. http://dx.doi.org/10.1016/j.iac.2006.09.005
  • 18. Cugno M, Zanichelli A, Foieni F, et al. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009;15:69-78. http://dx.doi.org/10.1016/j.molmed.2008.12.001
  • 19. Quastel M, Harrison R, Cicardi M, et al. Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 1983;71:1041-6. http://dx.doi.org/10.1172/JCI110831
  • 20. www.aid.org.tr- Herediter anjiyoödem çalışma grubu
Toplam 20 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırma Makaleleri
Yazarlar

Deniz Özçeker Bu kişi benim

Zeynep Tamay Bu kişi benim

Nermin Güler Bu kişi benim

Yayımlanma Tarihi 1 Ekim 2013
Yayımlandığı Sayı Yıl 2013

Kaynak Göster

APA Özçeker, D., Tamay, Z., & Güler, N. (2013). Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem. Çocuk Dergisi, 13(4), 167-170. https://doi.org/10.5222/j.child.2013.167
AMA Özçeker D, Tamay Z, Güler N. Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem. Çocuk Dergisi. Ekim 2013;13(4):167-170. doi:10.5222/j.child.2013.167
Chicago Özçeker, Deniz, Zeynep Tamay, ve Nermin Güler. “Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem”. Çocuk Dergisi 13, sy. 4 (Ekim 2013): 167-70. https://doi.org/10.5222/j.child.2013.167.
EndNote Özçeker D, Tamay Z, Güler N (01 Ekim 2013) Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem. Çocuk Dergisi 13 4 167–170.
IEEE D. Özçeker, Z. Tamay, ve N. Güler, “Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem”, Çocuk Dergisi, c. 13, sy. 4, ss. 167–170, 2013, doi: 10.5222/j.child.2013.167.
ISNAD Özçeker, Deniz vd. “Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem”. Çocuk Dergisi 13/4 (Ekim 2013), 167-170. https://doi.org/10.5222/j.child.2013.167.
JAMA Özçeker D, Tamay Z, Güler N. Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem. Çocuk Dergisi. 2013;13:167–170.
MLA Özçeker, Deniz vd. “Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem”. Çocuk Dergisi, c. 13, sy. 4, 2013, ss. 167-70, doi:10.5222/j.child.2013.167.
Vancouver Özçeker D, Tamay Z, Güler N. Yineleyen Anjiyoödemin Ender Nedeni: Herediter Anjiyoodem. Çocuk Dergisi. 2013;13(4):167-70.